A leading provider of specialist bio-decontamination products and services for the international Life Sciences, pharmaceutical and healthcare markets.
9-Jan-2018 – 282.6p – £63.5m – PER 29.1
Trading Update For The 12 Months To End December 2017 – Revenue will be ahead of expectations, £29.3m versus £26.8m last year. Pre-exceptional earnings before tax are expected to be significantly ahead of market expectations (to include an exceptional gain of £0.25m, disposal of the Airflow business). Net Cash of £14.5m.
Quite like this, it’s doubled in the past 12 months. Will keep an eye out for those results when they come through.
7-Mar-2018 – 322.5p – £72.5m – PER 28.0
Preliminary Results For The 12 Months To End December 2017 – Revenue up 6% (CC) to £29.2m (2016: £26.5 million), PBT of £3.3 million (2016: £0.1 million), Diluted EPS 10.8p (2016:1.2p) with Cash(and equivalents) at £14.6 million (2016: £8.8 million). 2018 has started in-line.
Doubled in the past 12 months but I don’t see enough here at present to tempt me.